Luca Triggiani

8PUBLICATIONS
47CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
Catalase Defines Radiotherapy Resistance and a Therapeutic Vulnerability in Rhabdomyosarcoma.

|Mar 28, 2026
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study.

Giorgio Facheris, Alessio Bruni, Valerio Nardone

|Nov 27, 2025
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP).

Marco Lorenzo Bonù, Jacopo Balduzzi, Gloria Pedersoli

|Jul 23, 2025
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know-A Review on Behalf of the Italian Association of Radiobiology (AIRB).

Marco Lorenzo Bonù, Andrea Georgopulos, Marco Ramera

|Apr 25, 2025
Treatment of Non-Hodgkin Lymphoma Involving Head and Neck Sites with a 1.5 T MR-Linac: Preliminary Results from a Prospective Observational Study.

Andrea Emanuele Guerini, Stefania Nici, Stefano Riga

|Mar 13, 2025
Real-World Insights into the Impact of Durvalumab on Stage III Unresectable Non-Small Cell Lung Cancer-A Narrative Review.

Giorgio Facheris, Gianluca Cossali, Jessica Imbrescia

Pageof 2

Frequent Collaborators

7 joint publications

Michela Buglione di Monale E Bastia

4 joint publications

Paolo Borghetti

4 joint publications

Stefano Maria Magrini

3 joint publications

Giorgio Facheris